Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
67028 participants
OBSERVATIONAL
2015-01-31
2020-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Chinese Atrial Fibrillation Registry
NCT06987825
Study of Atrial Fibrillation Combined with Atrial Functional Mitral Regurgitation
NCT06630936
New-Onset Atrial Fibrillation Complicating Acute Myocardial Infarction in China
NCT05511649
Specific Electrophenotypes in Atrial Fibrillation
NCT05366530
Promoting Atrial Fibrillation Screening in Primary Care
NCT06458829
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
American Heart Association
OTHER
Chinese Society of Cardiology
OTHER
Beijing Institute of Heart, Lung and Blood Vessel Diseases
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dong ZHAO
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dong Zhao, Ph. D
Role: PRINCIPAL_INVESTIGATOR
Beijing Institute of Heart, Lung and Blood Vessel Diseases
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Beijing An Zhen Hospital
Beijing, , China
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Hao Y, Liu J, Smith SC, Huo Y, Fonarow GC, Ge J, Liu J, Taubert KA, Morgan L, Guo Y, Zhou M, Zhao D, Ma C; CCC-AF Investigators. Rationale and design of the improving Care for Cardiovascular Disease in China (CCC) project: a national registry to improve management of atrial fibrillation. BMJ Open. 2018 Jul 5;8(7):e020968. doi: 10.1136/bmjopen-2017-020968.
Tong XY, Lin J, Sun ZQ, He Q, Zhan Y, Jiang CX, Tang RB, Sang CH, Ning M, Jia CQ, Feng L, Wang W, Zhao X, Li CY, Li SN, Guo XY, Liu T, Li MM, Yang N, Hao YC, Liu J, Liu J, Xie J, Long DY, Dong JZ, Zhao D, Ma CS. Low-density lipoprotein cholesterol levels and in-hospital bleeding in patients with atrial fibrillation: findings from CCC-AF project. Front Cardiovasc Med. 2025 Jun 12;12:1574796. doi: 10.3389/fcvm.2025.1574796. eCollection 2025.
Yang N, Sun Z, Liu J, Hao Y, Long D, Zhao D, Liu J; CCC-AF Investigators. Impact of insurance coverage for non-vitamin K antagonist oral anticoagulants on quality of care and care disparities in patients hospitalised with atrial fibrillation in tertiary hospitals in China: interrupted time series analysis. BMJ Open. 2025 Feb 22;15(2):e088539. doi: 10.1136/bmjopen-2024-088539.
Xia Y, Jiang J, Fan F, Pan Y, Zhou J, Zhang Y, Li J, Liu J, Yang N, Hao Y, Zhao D, Liu J, Ma C, Huo Y; CCC-AF investigators. Prevalence, Characteristics, and Treatment Strategy of Different Types of Heart Failure in Patients With Nonvalvular Atrial Fibrillation. J Am Heart Assoc. 2024 Oct;13(19):e033941. doi: 10.1161/JAHA.123.033941. Epub 2024 Sep 30.
Lin J, Long D, Jiang C, Sang C, Tang R, Li S, Wang W, Guo X, Ning M, Sun Z, Yang N, Hao Y, Liu J, Liu J, Du X, Morgan L, Fonarow GC, Smith SC Jr, Lip GYH, Zhao D, Dong J, Ma C; CCC-AF investigators. Oral anti-coagulants use in Chinese hospitalized patients with atrial fibrillation. Chin Med J (Engl). 2024 Jan 20;137(2):172-180. doi: 10.1097/CM9.0000000000002915. Epub 2023 Dec 22.
He P, Pan Y, Jiang J, Fan F, Zhou J, Xia Y, Liu J, Yang N, Hao Y, Li J, Liu J, Zhao D, Huo Y; CCC-AF investigators. In-hospital therapies and determinants of treatment strategy selection in patients with atrial fibrillation and left ventricular systolic dysfunction in China: a retrospective study based on the Improving Care for Cardiovascular Disease in China-Atrial Fibrillation (CCC-AF) project, 2015-2019. BMJ Open. 2023 Jun 5;13(6):e070070. doi: 10.1136/bmjopen-2022-070070.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CCC-AF-2014
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.